Lipidomic analyses reveal potential biomarkers for predicting death and heart failure after acute myocardial infarction

Area of Science:

• Cardiovascular Medicine
• Biomarker Discovery
• Lipidomics

Background:

• Acute myocardial infarction (AMI) and post-myocardial infarction heart failure (pMIHF) are leading causes of global mortality.
• Identifying reliable biomarkers for predicting adverse outcomes post-AMI is crucial for improving patient management.

Purpose of the Study:

• To investigate lipidomic profiles in patients following AMI.
• To identify potential lipid biomarkers for predicting mortality and the development of heart failure (HF) after AMI.

Main Methods:

• Serum samples were collected from patients at Xuanwu Hospital, Capital Medical University.
• Lipidomic profiles were analyzed using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
• Biomarkers were screened using Receiver Operating Characteristic (ROC) curve analysis.

Main Results:

• Decreased levels of specific sphingomyelins (SM), phosphatidylethanolamines (PE), phosphatidylcholines (PC), lysophosphatidylethanolamines (LPE), and lysophosphatidylcholines (LPC), along with increased phosphatidylglycerol (PG), were associated with increased risk of death post-AMI.
• Decreased levels of specific phosphatidylcholines (PC), lysophosphatidylcholines (LPC), and lysophosphatidylethanolamines (LPE) were associated with an increased risk of developing heart failure (HF) post-AMI.

Conclusions:

• Specific alterations in serum lipid profiles serve as potential predictive biomarkers for mortality and heart failure following acute myocardial infarction.
• These identified lipids warrant further investigation for clinical application in risk stratification after AMI.